// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Does Endobronchial Ultrasound-guided transbronchial needle aspiration (EBUS) alter the diagnosis in suspected Sarcoidosis?

Rashad Salman - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Sarcoidosis

N/A

Association between symptomatic improvements and outcome: responder analysis of SERVE-HF

Holger Woehrle - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

CPAP Therapy improves Depressive Symptoms in OSA Patients, including those using Antidepressant Medication

Robert Hooper - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Improving adherence to treatment in patients with obstructive sleep apnoea

Maria Del Carmen Mascare�o Ponte - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Blood pressure effects of obstructive sleep apnea treatment by continuous positive airway pressure: Systematic review, metaanalysis and evaluation of phenotypes predicting response

Martino Pengo - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea

Andras Bikov - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

Melatonin

Electrical stimulation as treatment for obstructive sleep apnoea: a meta-analysis

Culadeeban Ratneswaran - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Mechanisms of orthopnea in patients with advanced COPD

Amany Fathy Elbehairy - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Impact of excessive sleepiness associated with obstructive sleep apnea on work productivity in the United States

Laura Tesler Waldman - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

The prevalence and physiological profile of patients with overlap syndrome in a United Kingdom population

Stephanie K. Mansell - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Autoimmune sclerosing cholangitis

N/A

Neural respiratory drive and airway resistance in obstructive sleep apnoea

Esther Irene Schwarz - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

A proof of concept study describing extraoesophageal reflux in patients with obstructive sleep apnoea and asthma and the effects of continuous positive airway pressure

Zelal Kharaba - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Sleep apnoea

N/A

Cardiovascular and metabolic events in the MOSAIC randomised controlled trial: 5-year follow-up data

Christopher Turnbull - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Peripheral artery disease

N/A

Developing a digital health tool for stopping smoking in the thoracic surgery pathway

Sebastian Lugg - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Starting a uniportal VATS program - The Bonn experience

Benedetta Bedetti - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

The risk of surgical emphysema post VATS pleural biopsy and IPC

Thomas Nicholson - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Preoperative assessment for Lung Volume Reduction for emphysema – is a perfusion scan really necessary ?

Georgios Sotiropoulos - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Would lung cancer patients benefit from prehabilitation before surgery? Selecting optimisable patient variables

Elena Grattagliano - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

The staff smoking review

Jessica Gates - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Effect of quitting smoking on quality of life following a diagnosis of lung cancer

Rachel Gemine - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

INT131

Copyright © 2026. QuantiNova All rights reserved